Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Sterling IRB Announces New North American Panel

Sterling IRB
Posted on: 02 Oct 17
Sterling IRB Announces New North American Panel

PR Newswire

ATLANTA, Oct. 2, 2017

ATLANTA, Oct. 2, 2017 /PRNewswire/ -- Today the Sterling Institutional Review Board (Sterling IRB) announced its establishment of a new North American Panel to expand Sterling's program of ethical oversight for human subjects research. 

"While maintaining a steadfast focus on protecting research participants and regulatory compliance, we aim to streamline the ethical review process with end-to-end solutions," said Ted Green, President and CEO.  "The ability to directly oversee research sites in both Canada and the United States while maintaining our commitment to high standards will result in saving time and money for our clients."    

Sterling IRB has helped lead the way in safeguarding the rights and welfare of clinical research participants for more than 25 years.  As part of the company's commitment to streamline processes, Sterling IRB provides a single-point-of-contact that focuses on clients' specific needs.  Headquartered in Atlanta, Georgia, the company's clients include pharmaceutical and biotechnology companies, clinical research organizations (CROs), research institutions, hospitals, federal agencies and individual investigators.

For more information, contact:

Kathye Richards, CIP
Sterling Institutional Review Board
Vice President of Client Services

View original content:


PR Newswire

Last updated on: 02/10/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.